What is the recommended treatment for Chlamydia (Chlamydia trachomatis)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Chlamydia trachomatis

The recommended first-line treatment for uncomplicated chlamydial infection is either azithromycin 1 g orally in a single dose or doxycycline 100 mg orally twice daily for 7 days, both with efficacy rates of approximately 97-98%. 1, 2, 3

First-Line Treatment Options

  • Azithromycin 1 g orally in a single dose has advantages including directly observed therapy and better compliance, making it particularly useful when adherence to multi-day regimens is questionable 1, 3
  • Doxycycline 100 mg orally twice daily for 7 days has advantages including lower cost and extensive clinical experience 1, 3
  • Both medications are equally efficacious for genital chlamydial infections, with meta-analyses showing no statistically significant difference in microbial cure rates (97% for azithromycin vs 98% for doxycycline) 4

Alternative Treatment Options

  • Erythromycin base 500 mg orally four times a day for 7 days 5, 1
  • Erythromycin ethylsuccinate 800 mg orally four times a day for 7 days 5, 1
  • Ofloxacin 300 mg orally twice a day for 7 days 5, 1
  • Levofloxacin 500 mg orally once daily for 7 days 5, 1

Implementation Best Practices

  • Medications should be dispensed on-site when possible, with the first dose directly observed to maximize compliance 5, 1
  • Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen 5, 3
  • Patients should also abstain from sexual intercourse until all sex partners are treated to minimize risk of reinfection 5, 1

Special Populations

Pregnancy

  • Azithromycin 1 g orally in a single dose is recommended during pregnancy 2
  • Amoxicillin 500 mg orally three times a day for 7 days is an alternative option during pregnancy 1, 2
  • Doxycycline and fluoroquinolones (ofloxacin, levofloxacin) are contraindicated during pregnancy 2

Coinfection with Gonorrhea

  • Patients with gonorrhea often have co-infection with chlamydia (20-40%), and when treating gonorrhea, treatment for both infections should be provided if chlamydial infection has not been excluded 3

Partner Management

  • All sex partners from the previous 60 days should be evaluated, tested, and treated 1, 3
  • If the last sexual contact was >60 days before diagnosis, the most recent partner should still be treated 1

Follow-Up Recommendations

  • Test-of-cure is not routinely recommended after completing treatment with recommended regimens unless therapeutic compliance is questionable, symptoms persist, or reinfection is suspected 1, 3
  • Consider retesting women approximately 3 months after treatment due to high risk of reinfection 1, 3

Clinical Considerations and Pitfalls

  • Gastrointestinal side effects are common with both treatments (25% for azithromycin vs 23% for doxycycline) but are generally mild to moderate 4
  • Erythromycin often causes gastrointestinal side effects that lead to poor compliance, making it a less desirable alternative 1, 3
  • Treatment failure is uncommon with recommended regimens, with failure rates of 0-3% for males and 0-8% for females 1
  • When selecting between azithromycin and doxycycline, consider patient compliance factors and cost - azithromycin is preferred when compliance is a concern, while doxycycline is generally less expensive 1, 6

References

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Chlamydia and Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.